Obalon Therapeutics Inc (OBLN) Price Targets From Analysts
Use the tables below to see what analysts covering Obalon Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued May 28, 2021
The Trend in the Analyst Price Target
Over the past 41 days, OBLN's average price target has gone down $0.
Over the past 50 weeks, OBLN's average upside potential has been 41.54%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
OBLN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for OBLN as an investment opportunity.
- OBLN has a greater number of analysts covering the stock than nearly none of all US stocks.
- OBLN has a less variance in analysts' estimates than nearly 100% of all US stocks.
- OBLN has a greater average analyst price target than 11.83% of all US stocks.
- OBLN has a greater upside potential (average analyst target price relative to current price) than 86.03% of all US stocks.
What is the outlook for OBLN? Use POWR Ratings for clearer insight into price direction.